To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

This bill requires the Food and Drug Administration to tell companies that want to make generic drugs whether their drug is the same as the original brand-name drug. If the generic drug is not the same, the FDA must explain why. The FDA must also create or update guidance that explains how it decides whether generic drugs are the same as brand-name drugs.

Your Vote